DGS Capital Management »

Eagle Pharmaceuticals shares owned by DGS Capital Management

Quarter-by-quarter ownership of Eagle Pharmaceuticals (EGRX) shares owned by DGS Capital Management from 13F filings

Historical chart of DGS Capital Management investment in Eagle Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eagle Pharmaceuticals held by DGS Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eagle Pharmaceuticals by DGS Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $325k 62k 5.24
2023-12-31 $60k 11k 5.23

More positions owned by DGS Capital Management

Coinbase Global Inc Com Cl A Stock (COIN)
Ishares Short-term National Muni Bond Etf Etf (SUB)
Microsoft Corp Stock (MSFT)
Apple Stock (AAPL)
Nvidia Corporation Stock (NVDA)
Spdr Portfolio Short Term Treasury Etf Etf (SPTS)
Meta Platforms Inc Cl A Stock (META)
Ishares Global Equity Factor Etf Etf (GLOF)
Novo-nordisk A S Adr (NVO)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Amazon Stock (AMZN)
Sk Telecom Adr (SKM)
Cgi Inc Cl A Sub Vtg Stock (GIB)
Honda Motor Ltd Adr Ech Cnv In 3 Adr (HMC)
Celestica Inc Sub Vtg Stock (CLS)

View all positions for DGS Capital Management

Top funds holding Eagle Pharmaceuticals

Henderson Group
Brandes Investment Partners
Vanguard Group
Millennium Management
AQR Capital Management
LSV Asset Management
J. Goldman & Co
Dimensional Fund Advisors
Two Sigma Advisers
Two Sigma Investments
Goldman Sachs Group
Thomas Stevens, CFA"
Bank of America Corporation
Assenagon Asset Management
D. E. Shaw & Co

View all funds holding Eagle Pharmaceuticals